The Role of Neurofilament Light (NfL) in Patients With Hydrocephalus
- Conditions
- HydrocephalusGeneral Anesthetics ToxicityBrain Damage
- Interventions
- Diagnostic Test: Lumbar punctureDiagnostic Test: External lumbar drainageDiagnostic Test: Lumbar infusion testProcedure: Ventriculo-peritoneal shunt placementProcedure: Blood sampling #3Procedure: General AnesthesiaProcedure: Prechamber punctureProcedure: Blood sampling #1Procedure: Blood sampling #2Procedure: Blood sampling #4 and #5
- Registration Number
- NCT05399602
- Lead Sponsor
- University Hospital Hradec Kralove
- Brief Summary
Neurofilament Light Chain Protein (NfL) has been found by many studies as a sensitive biomarker of neuronal damage from several reasons, e.g. neurodegenerative diseases (Alzheimer's disease, Multiple Sclerosis, etc.), inflamation (HIV) or trauma. Its role as biomarker thus offers a possibility to predict and manage diseases associated with neuronal damage. Therefore our aim is to investigate the changes in level of NfL in hydrocephalus and to find its role in management of treatment in hydrocephalus.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 20
-
In group A:
- Patients with diagnosed communicating hydrocephalus
- MMSE > 10 points
- Absence of any structural laesion on MRI or CT
- Accepted Informed consent
-
In group B:
- MMSE > 10 points
- Absence of any structural laesion on MRI or CT
- Accepted Informed consent
- Elective spinal surgery without affecting dural sac and the spinal cord
- Surgery shorter than 120 minutes of lasting the general anesthesia
- Non-communicating hydrocephalus
- Structural laesion on MRI or CT (tumour, contusion, aneurysm)
- MMSE < 10 points
- Life-expectancy shorter than 1 year
- Pre-existing other type of demetia (m. Alzheimer, vascular dementia)
- Surgery lasting more than 120 minutes
- Blood loss more than 500 ml
- Opening of dural sac (liquororhea)
- Adverse events during general anestesia: MAP<60 mm Hg more than 5 minutes, arythmia with need for farmacological treatment
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Study group A General Anesthesia Patients with diagnosed hydrocephalus undergoing surgery (VP shunt placement) in general anestezia. Before surgery patients undergo lumbar puncture or external lumbar drainage placement to confirmate the diagnosis and responsivity to VP shunt placement. Study group A Prechamber puncture Patients with diagnosed hydrocephalus undergoing surgery (VP shunt placement) in general anestezia. Before surgery patients undergo lumbar puncture or external lumbar drainage placement to confirmate the diagnosis and responsivity to VP shunt placement. Study group A Blood sampling #2 Patients with diagnosed hydrocephalus undergoing surgery (VP shunt placement) in general anestezia. Before surgery patients undergo lumbar puncture or external lumbar drainage placement to confirmate the diagnosis and responsivity to VP shunt placement. Study group B General Anesthesia Patients without diagnosed hydrocephalus undergoing short spinal surgery without affecting dural sac (e.g. anterior cervical discectomy and fusion or lumbar disc herniation or lumbar decompression) in general anestezia. Study group A Lumbar puncture Patients with diagnosed hydrocephalus undergoing surgery (VP shunt placement) in general anestezia. Before surgery patients undergo lumbar puncture or external lumbar drainage placement to confirmate the diagnosis and responsivity to VP shunt placement. Study group A External lumbar drainage Patients with diagnosed hydrocephalus undergoing surgery (VP shunt placement) in general anestezia. Before surgery patients undergo lumbar puncture or external lumbar drainage placement to confirmate the diagnosis and responsivity to VP shunt placement. Study group A Lumbar infusion test Patients with diagnosed hydrocephalus undergoing surgery (VP shunt placement) in general anestezia. Before surgery patients undergo lumbar puncture or external lumbar drainage placement to confirmate the diagnosis and responsivity to VP shunt placement. Study group A Ventriculo-peritoneal shunt placement Patients with diagnosed hydrocephalus undergoing surgery (VP shunt placement) in general anestezia. Before surgery patients undergo lumbar puncture or external lumbar drainage placement to confirmate the diagnosis and responsivity to VP shunt placement. Study group B Blood sampling #3 Patients without diagnosed hydrocephalus undergoing short spinal surgery without affecting dural sac (e.g. anterior cervical discectomy and fusion or lumbar disc herniation or lumbar decompression) in general anestezia. Study group A Blood sampling #1 Patients with diagnosed hydrocephalus undergoing surgery (VP shunt placement) in general anestezia. Before surgery patients undergo lumbar puncture or external lumbar drainage placement to confirmate the diagnosis and responsivity to VP shunt placement. Study group A Blood sampling #3 Patients with diagnosed hydrocephalus undergoing surgery (VP shunt placement) in general anestezia. Before surgery patients undergo lumbar puncture or external lumbar drainage placement to confirmate the diagnosis and responsivity to VP shunt placement. Study group B Blood sampling #1 Patients without diagnosed hydrocephalus undergoing short spinal surgery without affecting dural sac (e.g. anterior cervical discectomy and fusion or lumbar disc herniation or lumbar decompression) in general anestezia. Study group B Blood sampling #2 Patients without diagnosed hydrocephalus undergoing short spinal surgery without affecting dural sac (e.g. anterior cervical discectomy and fusion or lumbar disc herniation or lumbar decompression) in general anestezia. Study group A Blood sampling #4 and #5 Patients with diagnosed hydrocephalus undergoing surgery (VP shunt placement) in general anestezia. Before surgery patients undergo lumbar puncture or external lumbar drainage placement to confirmate the diagnosis and responsivity to VP shunt placement.
- Primary Outcome Measures
Name Time Method Number of changes in valve settings 3 months after surgery To investigate the number of changes in valve settings according the patient's clinical state based on clinical examination, CT examination or telemetrically measured CSF pressure
Recruitment rate 6 months To assess the number of patients recruited in a pilot study. Recruitment rate is one of the predictor of feasibility of a study
- Secondary Outcome Measures
Name Time Method Correlation between NfL level and patient's clinical state 3 months after surgery To investigate in group A the correlation between the level of NfL get from CSF and blood sampling and observation in changes in patient's clinical state measured by mini-mental state examination (MMSE), 5-meter-walking test and patient's self-assessment questionare
Trial Locations
- Locations (1)
University Hospital Hradec Kralove
🇨🇿Hradec Králové, Czechia